Benign Neoplasm
9
2
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
33%
3 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (9)
Bone Marrow Transplantation Using CD34-Selected Stem Cells From Related or Unrelated Donors in Treating Participants With Cancer or Other Disorders
Fluid Challenge and Plasma Volume, During Surgery
Intraoperative Tumor Margin Identification With ICG Dye Imaging
Virtual Surgical Planning in Mandibular Segmental Resection
Endoscopic Surgery for Gastrointestinal Disorders: A Multicenter Registry Study
Liposomal Bupivacaine in Benign Soft Tissue Tumor Resection
Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant
Role of PET/MRI in Head and Neck Cancer
Deep Biopsy Via Endoscopic Submucosal Dissection in Upper GI Subepithelial Tumors